Literature DB >> 10390410

Maximizing the utilization of donor organs offered for lung transplantation.

E Gabbay1, T J Williams, A P Griffiths, L M Macfarlane, T C Kotsimbos, D S Esmore, G I Snell.   

Abstract

The number of patients awaiting lung transplantation (LT) and waiting time for surgery is increasing. In Australia, LT rates are 4. 6/million population/yr, which despite low organ donation rates, are the highest published in the world. The Australian organ allocation system allows identification of marginal donors and therapeutic manipulation where appropriate. This study aims to assess the impact of utilization of marginal donors and aggressive donor management. A comparison between published donor criteria and local practice is made, allowing assessment of the effect of using marginal donors on outcome. Donor management included antibiotic therapy, strict fluid management, physiotherapy, bronchoscopy and bronchial toilet, and alteration of ventilatory settings including initiation of pressure support. Blood gases were repeated to assess the results of interventions. Between January 1, 1995 and May 31, 1998, we performed 140 transplants from 112 of 219 (51%) lung donor offers. Of these donors, 48 (43%) satisfied all published criteria for suitable donor organs (Group 1 = ideal donors) and 64 (57%) did not (Group 2 = marginal donors). Criteria breached by the marginal donors were: an initial ratio of arterial oxygen pressure to fraction of inspired oxygen (PaO2/FIO2) < 300 mm Hg (n = 20), abnormal radiology (n = 39), pulmonary infection (n = 24), 20 pack-years smoking (n = 5) and age > 55 yr (n = 4). Therapeutic manipulation resulted in improvement in the PaO2/FIO2 ratio in 20 donors (Group 3) who would not otherwise have been used. Immediate and 24 h postoperative gas exchange and length of intensive care unit (ICU) stay was not different for recipients from donors from all three groups. Overall survival was 94% at 30 d, 83% at 1 yr, 70% at 2 yr, and 62% at 3 yr and was not significantly different from the three groups. We conclude that organ utilization can be maximized by therapeutic manipulation and utilization of marginal donors without compromising results from transplantation.

Entities:  

Mesh:

Year:  1999        PMID: 10390410     DOI: 10.1164/ajrccm.160.1.9811017

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  24 in total

Review 1.  [Organ protective intensive care treatment and simulation-based training].

Authors:  J W Rey; T Ott; D Bösebeck; S Welschehold; P R Galle; C Werner
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

Review 2.  [Lung transplantation. Possibilities and limitations].

Authors:  J Gottlieb; T Welte; M M Höper; M Strüber; J Niedermeyer
Journal:  Internist (Berl)       Date:  2004-11       Impact factor: 0.743

Review 3.  Special issues in the management and selection of the donor for lung transplantation.

Authors:  Priyumvada M Naik; Luis F Angel
Journal:  Semin Immunopathol       Date:  2011-04-15       Impact factor: 9.623

4.  Impact of Donor Arterial Partial Pressure of Oxygen on Outcomes After Lung Transplantation in Adult Cystic Fibrosis Recipients.

Authors:  Don Hayes; Benjamin T Kopp; Stephen E Kirkby; Susan D Reynolds; Heidi M Mansour; Joseph D Tobias; Dmitry Tumin
Journal:  Lung       Date:  2016-06-08       Impact factor: 2.584

5.  Organ Donation : Intensive Care Issues in Managing Brain Dead.

Authors:  Tvsp Murthy
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 6.  Critical care of the potential organ donor.

Authors:  Anna J Dare; Adam S Bartlett; John F Fraser
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 7.  Does the use of extended criteria donors influence early and long-term results of lung transplantation?

Authors:  Marco Schiavon; Pierre-Emmanuel Falcoz; Nicola Santelmo; Gilbert Massard
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-25

Review 8.  Primary graft dysfunction.

Authors:  Yoshikazu Suzuki; Edward Cantu; Jason D Christie
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

Review 9.  Lung donor selection criteria.

Authors:  John Chaney; Yoshikazu Suzuki; Edward Cantu; Victor van Berkel
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

Review 10.  Overview of lung transplantation.

Authors:  Marlyn S Woo
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.